Annual Current Liabilities
$5.55 M
-$1.38 M-19.90%
December 31, 2023
Summary
- As of February 6, 2025, SBFM annual total current liabilities is $5.55 million, with the most recent change of -$1.38 million (-19.90%) on December 31, 2023.
- During the last 3 years, SBFM annual current liabilities has risen by +$4.50 million (+428.09%).
- SBFM annual current liabilities is now -99.99% below its all-time high of $55.20 billion, reached on December 1, 2002.
Performance
SBFM Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$4.53 M
-$771.00 K-14.55%
September 30, 2024
Summary
- As of February 6, 2025, SBFM quarterly total current liabilities is $4.53 million, with the most recent change of -$771.00 thousand (-14.55%) on September 30, 2024.
- Over the past year, SBFM quarterly current liabilities has dropped by -$559.60 thousand (-11.00%).
- SBFM quarterly current liabilities is now -34.66% below its all-time high of $6.93 million, reached on December 31, 2022.
Performance
SBFM Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
SBFM Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.9% | -11.0% |
| 3 y3 years | +428.1% | -2.8% |
| 5 y5 years | +508.4% | -2.8% |
SBFM Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.9% | +5987.5% | -34.7% | +4865.5% |
| 5 y | 5-year | -19.9% | +5987.5% | -34.7% | +4865.5% |
| alltime | all time | -100.0% | >+9999.0% | -34.7% | -100.0% |
Sunshine Biopharma Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.53 M(-14.5%) |
| Jun 2024 | - | $5.30 M(-18.9%) |
| Mar 2024 | - | $6.53 M(+17.7%) |
| Dec 2023 | $5.55 M(-19.9%) | $5.55 M(+9.1%) |
| Sep 2023 | - | $5.09 M(+9.2%) |
| Jun 2023 | - | $4.66 M(-32.5%) |
| Mar 2023 | - | $6.91 M(-0.4%) |
| Dec 2022 | $6.93 M(+7499.8%) | $6.93 M(+1343.4%) |
| Sep 2022 | - | $480.20 K(+358.6%) |
| Jun 2022 | - | $104.70 K(+10.0%) |
| Mar 2022 | - | $95.20 K(+4.4%) |
| Dec 2021 | $91.20 K(-91.3%) | - |
| Dec 2021 | - | $91.20 K(-80.7%) |
| Sep 2021 | - | $471.60 K(-25.8%) |
| Jun 2021 | - | $635.60 K(-26.5%) |
| Mar 2021 | - | $864.80 K(-17.7%) |
| Dec 2020 | $1.05 M(+26.1%) | $1.05 M(+40.6%) |
| Sep 2020 | - | $747.80 K(+9.0%) |
| Jun 2020 | - | $686.20 K(-11.1%) |
| Mar 2020 | - | $772.30 K(-7.3%) |
| Dec 2019 | $833.50 K(-8.7%) | $833.50 K(-6.3%) |
| Sep 2019 | - | $889.20 K(-3.9%) |
| Jun 2019 | - | $925.70 K(-17.3%) |
| Mar 2019 | - | $1.12 M(+22.7%) |
| Dec 2018 | $912.50 K(+21.5%) | $912.50 K(+22.1%) |
| Sep 2018 | - | $747.10 K(-34.3%) |
| Jun 2018 | - | $1.14 M(-3.7%) |
| Mar 2018 | - | $1.18 M(+57.2%) |
| Dec 2017 | $751.10 K(+174.0%) | $751.10 K(+23.2%) |
| Sep 2017 | - | $609.90 K(-21.9%) |
| Jun 2017 | - | $780.60 K(+174.4%) |
| Mar 2017 | - | $284.50 K(+3.8%) |
| Dec 2016 | $274.10 K(-78.4%) | $274.10 K(-0.9%) |
| Sep 2016 | - | $276.70 K(-77.2%) |
| Jun 2016 | - | $1.21 M(+2.3%) |
| Mar 2016 | - | $1.19 M(-6.6%) |
| Dec 2015 | $1.27 M | $1.27 M(+170.5%) |
| Sep 2015 | - | $469.60 K(+7.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $436.10 K(+15.0%) |
| Mar 2015 | - | $379.20 K(-28.6%) |
| Dec 2014 | $531.00 K(+1265.0%) | $531.00 K(+16.3%) |
| Sep 2014 | - | $456.60 K(+19.4%) |
| Jun 2014 | - | $382.30 K(+106.6%) |
| Mar 2014 | - | $185.00 K(+375.6%) |
| Dec 2013 | $38.90 K(-39.6%) | $38.90 K(+65.5%) |
| Sep 2013 | - | $23.50 K(+59.9%) |
| Jun 2013 | - | $14.70 K(-34.4%) |
| Mar 2013 | - | $22.40 K(-65.2%) |
| Dec 2012 | $64.40 K(+1794.1%) | $64.40 K(+332.2%) |
| Sep 2012 | - | $14.90 K(-49.3%) |
| Jun 2012 | - | $29.40 K(+43.4%) |
| Mar 2012 | - | $20.50 K(+502.9%) |
| Dec 2011 | $3400.00(-70.2%) | $3400.00(-24.4%) |
| Sep 2011 | - | $4500.00(>+9900.0%) |
| Jun 2011 | - | $0.00(-100.0%) |
| Mar 2011 | - | $300.00(-97.4%) |
| Dec 2010 | $11.40 K(-20.3%) | $11.40 K(-52.1%) |
| Sep 2010 | - | $23.80 K(+42.5%) |
| Jun 2010 | - | $16.70 K(+4.4%) |
| Mar 2010 | - | $16.00 K(>+9900.0%) |
| Dec 2009 | $14.30 K(-67.1%) | - |
| Oct 2009 | - | $0.00(-100.0%) |
| Jul 2009 | $43.40 K(+91.2%) | $43.40 K(+25.4%) |
| Apr 2009 | - | $34.60 K(+18.1%) |
| Jan 2009 | - | $29.30 K(+9.7%) |
| Oct 2008 | - | $26.70 K(+17.6%) |
| Jul 2008 | $22.70 K(+1413.3%) | $22.70 K(+30.5%) |
| Apr 2008 | - | $17.40 K(+596.0%) |
| Jan 2008 | - | $2500.00(-24.2%) |
| Oct 2007 | - | $3300.00 |
| Jul 2007 | $1500.00(-100.0%) | - |
| Dec 2003 | $54.42 B(-1.4%) | - |
| Dec 2002 | $55.20 B(+64.9%) | - |
| Dec 2001 | $33.47 B(-21.6%) | - |
| Dec 2000 | $42.70 B(+27.6%) | - |
| Dec 1999 | $33.46 B(+7.5%) | - |
| Dec 1998 | $31.14 B | - |
FAQ
- What is Sunshine Biopharma annual total current liabilities?
- What is the all time high annual current liabilities for Sunshine Biopharma?
- What is Sunshine Biopharma annual current liabilities year-on-year change?
- What is Sunshine Biopharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly current liabilities year-on-year change?
What is Sunshine Biopharma annual total current liabilities?
The current annual current liabilities of SBFM is $5.55 M
What is the all time high annual current liabilities for Sunshine Biopharma?
Sunshine Biopharma all-time high annual total current liabilities is $55.20 B
What is Sunshine Biopharma annual current liabilities year-on-year change?
Over the past year, SBFM annual total current liabilities has changed by -$1.38 M (-19.90%)
What is Sunshine Biopharma quarterly total current liabilities?
The current quarterly current liabilities of SBFM is $4.53 M
What is the all time high quarterly current liabilities for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly total current liabilities is $6.93 M
What is Sunshine Biopharma quarterly current liabilities year-on-year change?
Over the past year, SBFM quarterly total current liabilities has changed by -$559.60 K (-11.00%)